Viewing nowJ-Gaba Capsules 25 mg (Pregabalin)
Pregabalin 25mg
Hard capsule · Prescription medication
Chaeil Pharmaceutical Co., Ltd.

MFDS item code 201900208 · Approved 2019.01.16 · Insurance code 645406470
Treatment of peripheral and central neuropathic pain, adjunctive effect for partial seizures in epilepsy, improvement of fibromyalgia.
This medication is used to treat peripheral and central neuropathic pain in adults. It is also utilized as an adjunctive treatment for partial seizures in epilepsy patients, both with and without secondary generalized symptoms. Additionally, it is effective in treating fibromyalgia. It helps improve the symptoms of patients by aiding various neurological disorders and pain management.
This medication is given orally as pregabalin, divided into two doses daily, without regard to food. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose is 150 mg daily, can increase to 300 mg daily within 3 to 7 days, and may increase up to 600 mg daily at intervals of 7 days if needed. - Central neuropathic pain: Starting dose is 150 mg daily, can increase as per the patient's response and tolerance.
Safety and effectiveness data are insufficient for pediatric patients under 12 years of age and adolescents aged 12-17 years, so use is not recommended.
This medication may increase the risk of suicidal thoughts or behavior, so careful observation for mood changes or abnormal behavior is necessary during treatment. Individuals who are allergic to any of the components of this drug or who have certain genetic lactose-related disorders should not take it. Diabetic patients may experience weight gain after taking this medication, necessitating adjustments in their medication dosage for blood glucose control. If allergic reactions manifest as facial or oral swelling (angioedema), stop taking this medication immediately. Elderly patients may experience increased dizziness or drowsiness while taking this drug, thus requiring caution to prevent falls or injuries. This medication may cause blurred vision or other vision changes, so consult a physician if these occur. Abruptly stopping this medication may lead to withdrawal symptoms such as insomnia, headaches, nausea, and anxiety, thus it should be reduced gradually in consultation with a healthcare professional. Patients with a history of drug abuse may be at higher risk for misuse of this medication and should be carefully monitored. Patients with impaired kidney function may require dosage adjustments of this medication. Patients with heart conditions may develop heart failure symptoms while on this medication and should use it cautiously. Taking this medication with opioid analgesics may enhance central nervous system depressant effects, leading to risks such as respiratory difficulties, and should be approached with care. Avoid hazardous activities such as driving or operating machinery until dizziness or drowsiness has subsided following the use of this medication. During early pregnancy, this medication may affect the fetus, so it is essential for pregnant women to consult a physician before use, and women of childbearing age should employ effective contraception. Breastfeeding women should consult with their healthcare provider regarding whether to discontinue breastfeeding or the medication, as this drug can be passed into breast milk. In case of overdose, symptoms may include drowsiness, confusion, and depression, and appropriate treatment such as hemodialysis may be needed. This medication should be stored out of reach of children and transferring it to another container should be avoided. If serious adverse reactions such as skin rash, fever, or breathing difficulties occur during treatment, medication should be stopped immediately and healthcare professionals notified.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, jaundice (yellowing of the skin or eyes), extreme sleepiness throughout the body, sudden and severe headaches, lightning-like headaches, seizures, altered consciousness, visual disturbances, paralysis, urinary issues
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container, protected from air and moisture. Maintain storage temperature between 15 and 30 degrees Celsius.
A hard capsule with a pale yellow upper part and white lower part containing white powder.
30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 25mg
Hard capsule · Prescription medication
Chaeil Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.